Dianthus Therapeutics Inc (DNTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -84,969 | -56,529 | -31,355 | -13,748 | -43,555 |
| Depreciation Amortization | -5,606 | -2,947 | -722 | -411 | -1,068 |
| Accounts receivable | -513 | -1,096 | -546 | -141 | 4,406 |
| Accounts payable and accrued liabilities | 8,191 | 5,911 | 260 | -2,986 | 661 |
| Other Working Capital | -351 | 71 | -2,528 | -2,817 | 4,862 |
| Other Operating Activity | 5,068 | 3,854 | 5,422 | 5,162 | -2,167 |
| Operating Cash Flow | $-78,180 | $-50,736 | $-29,469 | $-14,941 | $-36,861 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -286,707 | -263,628 | -4,289 | 15,000 | 20,363 |
| PPE Investments | -105 | -74 | -49 | -32 | -110 |
| Purchase Of Investment | N/A | N/A | N/A | -20,475 | N/A |
| Investing Cash Flow | $-286,812 | $-263,702 | $-4,338 | $-5,507 | $20,253 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 377 |
| Debt Repayment | N/A | N/A | N/A | N/A | -377 |
| Common Stock Issued | 40,290 | 614 | 318 | 271 | 5 |
| Other Financing Activity | 215,333 | 215,333 | 215,333 | 217,576 | 133,569 |
| Financing Cash Flow | $255,623 | $215,947 | $215,651 | $217,847 | $133,574 |
| Beginning Cash Position | 132,391 | 132,391 | 132,391 | 132,391 | 15,425 |
| End Cash Position | 23,022 | 33,900 | 314,235 | 329,790 | 132,391 |
| Net Cash Flow | $-109,369 | $-98,491 | $181,844 | $197,399 | $116,966 |
| Free Cash Flow | |||||
| Operating Cash Flow | -78,180 | -50,736 | -29,469 | -14,941 | -36,861 |
| Capital Expenditure | -105 | -74 | -49 | -32 | -110 |
| Free Cash Flow | -78,285 | -50,810 | -29,518 | -14,973 | -36,971 |